California

The Department of Health Care Services (DHCS) posted the following alerts, weekly notices, and monthly bulletin on the Medi-Cal Rx Web Portal:  

• Policy Reminder: Limitations on Coverage of Certain Drugs or Classes of Drugs (April 24) 
• NCPDP Reject Code 76: Continuous Glucose Monitor (CGM) Supplies (April 21) 

• Medi-Cal Rx Weekly Wrap-up for April 14-20 (April 21) 
• Reinstatement Spotlight (April 21) 
• 30-day Countdown – Phase III, Lift 3: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older (April 19) 
• Medi-Cal Rx Weekly Wrap-up for April 7-13 (April 14) 
• Reinstatement Spotlight (April 14) 

• Changes to the Family PACT Pharmacy Formulary (April 12) 
• Medication Abortion: Coverage of Misoprostol-Only Regimen (April 11) 
• Medi-Cal Rx Weekly Wrap-up for March 31-April 6 (April 7) 
• Reinstatement Spotlight (April 7) 
• Mpox Vaccine: Change in Reimbursement Rate (April 5) 

• Updated: Patient Counseling Signature Requirements in Provider Manual (April 1) 
• Medi-Cal Rx Monthly Bulletin for April (April 1) 
• Changes to the Contract Drugs List (CDL) (April 1) 
• Changes to the Contract Drugs List (CDL) – Authorized Drug Manufacturer Labeler Codes (April 1) 
• Updates to the Medi-Cal Rx Provider Manual (April 1) 

• Medi-Cal Rx Weekly Wrap-up for March 24-30 (March 31) 
• Reinstatement Spotlight (March 31) 
• Mpox Vaccine No Longer a Family PACT Pharmacy Benefit (March 30) 

Also in California, Medi-Cal posted the following:    

• Medi-Cal Update – Pharmacy – April 2023 – Bulletin 1037 (April 14) 
• Medi-Cal Update – Durable Medical Equipment and Medical Supplies – April 2023 – Bulletin 571 (April 14) 
• Policy Update of Mpox Vaccines as a Medi-Cal Benefit (April 5) 
• Update: Discontinuation of the Coronavirus (COVID-19) Uninsured Group Program on May 31 (April 3) 

Also in California, the Board of Pharmacy posted the agenda and meeting materials for the Standard of Care Ad Hoc Committee meeting on May 3. 

Finally in California, the Board of Pharmacy is accepting written comments on the following: 

• Title 16 CCR § 1715.1 – Self-Assessment of an Automated Drug Delivery System 

• Notice of Additional Modified Text 
• Modified Text 
• Modified Self-Assessment Form 
• Deadline for Written Comments is May 6. 

• Title 16 CCR § 1706.6 – Temporary Licenses for Military Spouses/Domestic Partners 

• Notice of Proposed Action 
• Initial Statement of Reasons 
• Proposed Text 
• Deadline for Written Comments is May 30. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.